Ivuxolimab is a monoclonal antibody that acts as an agonist to OX40, also identified as CD134 or TNFRSF4. This costimulatory receptor is predominantly expressed on activated CD4+ and CD8+ T cells. The antibody is designed to enhance immune responses and has demonstrated significant antitumor activity, suggesting its utility in immunotherapy applications.
Ivuxolimab is a monoclonal antibody that acts as an agonist to OX40, also identified as CD134 or TNFRSF4. This costimulatory receptor is predominantly expressed on activated CD4+ and CD8+ T cells. The antibody is designed to enhance immune responses and has demonstrated significant antitumor activity, suggesting its utility in immunotherapy applications.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
